Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis

Akinori Morita, Shinya Ariyasu, Soichiro Ohya, Ippei Takahashi, Bing Wang, Kaoru Tanaka, Takatoshi Uchida, Haruna Okazaki, Kengo Hanaya, Atsushi Enomoto, Mitsuru Nenoi, Masahiko Ikekita, Shin Aoki, Yoshio Hosoi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-μ (PFTμ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N'-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.

Original languageEnglish
Pages (from-to)2439-2450
Number of pages12
JournalOncotarget
Volume4
Issue number12
DOIs
Publication statusPublished - 2013 Dec

Keywords

  • Apoptosis
  • Radiation
  • Zinc binding site
  • Zinc chelator
  • p53

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis'. Together they form a unique fingerprint.

  • Cite this

    Morita, A., Ariyasu, S., Ohya, S., Takahashi, I., Wang, B., Tanaka, K., Uchida, T., Okazaki, H., Hanaya, K., Enomoto, A., Nenoi, M., Ikekita, M., Aoki, S., & Hosoi, Y. (2013). Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis. Oncotarget, 4(12), 2439-2450. https://doi.org/10.18632/oncotarget.1535